Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of a fentanyl vaccine
NL-OMON58835Phase 2Recruiting
- Sponsor
- ARMR Sciences
- Start
- Feb 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of fentanyl vaccine in opioid intoxication, sponsored by ARMR Sciences. Started Feb 2026; status: recruiting.
02
Drugs
fentanyl vaccine
03
Conditions
opioid intoxication
Beyond the preview
Go deeper on NL-OMON58835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58835.